recombinant sars-cov-2 spike protein (omicron jn.1) with matrix-m adjuvant

Italy

Drugs containing this active substance

NUVAXOVID JN.1

It is a vaccine used for the prevention of COVID-19, the disease caused by the SARS-CoV-2 virus.

Form: solution for injection

Active substance	Dosage
recombinant sars-cov-2 spike protein (omicron jn.1) with matrix-m adjuvant	-